Addus HomeCare Analyst Ratings and Price Targets | NASDAQ:ADUS

Comments

Addus HomeCare Corp Analyst Ratings

ADUSNASDAQ

Trade with Public

$112.66

-1.14-1.00%

Last update: Feb 17, 1:00 PM

Earnings: Q4 2025 Earnings in 6 days from now on Mon Feb 23rd, after the market close

Conference Call: Conference call scheduled in 7 days at 9:00 AM

Click to view the webcast

Overview News Earnings OptionsAnalyst RatingsInsider Trades Short Interest Stock Report

Consensus Rating¹

Outperform

Highest Price Target¹

$150.00

Lowest Price Target¹

$105.00

Consensus Price Target¹

$136.47

Addus HomeCare Analyst Ratings and Price Targets | NASDAQ:ADUS | Benzinga

Addus HomeCare Corp has a consensus price target of $136.47 based on the ratings of 16 analysts. The high is $150 issued by JMP Securities on July 16, 2025. The low is $105 issued by Raymond James on August 2, 2023. The 3 most-recent analyst ratings were released by BMO Capital, RBC Capital, and TD Cowen on November 13, 2025, November 7, 2025, and November 5, 2025, respectively. With an average price target of $133 between BMO Capital, RBC Capital, and TD Cowen, there's an implied 18.05% upside for Addus HomeCare Corp from these most-recent analyst ratings.

Analyst Trends and Forecast

Aug 25

Sep 25

Nov 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Analyst Firms Making Recommendations¹

BMO Capital

RBC Capital

TD Cowen

Barclays

Stephens & Co.

¹calculated from analyst ratings

Analyst Ratings for Addus HomeCare

	Buy Now						Get Alert
11/13/2025	Buy Now	6.51%	BMO Capital	→ $120	Initiates	→ Market Perform	Get Alert
11/07/2025	Buy Now	23.38%	RBC Capital	$134 → $139	Maintains	Outperform	Get Alert
11/05/2025	Buy Now	24.26%	TD Cowen	$139 → $140	Maintains	Buy	Get Alert
11/04/2025	Buy Now	3.85%	Barclays	$111 → $117	Maintains	Underweight	Get Alert
09/03/2025	Buy Now	24.26%	Stephens & Co.	$140 → $140	Reiterates	Overweight → Overweight	Get Alert
09/02/2025	Buy Now	28.7%	UBS	→ $145	Initiates	→ Buy	Get Alert
08/22/2025	Buy Now	18.94%	RBC Capital	$133 → $134	Maintains	Outperform	Get Alert
08/19/2025	Buy Now	-3.25%	Barclays	$83 → $109	Maintains	Underweight	Get Alert
08/06/2025	Buy Now	23.38%	TD Cowen	$135 → $139	Maintains	Buy	Get Alert
07/31/2025	Buy Now	18.05%	RBC Capital	$136 → $133	Maintains	Outperform	Get Alert
07/16/2025	Buy Now	33.14%	JMP Securities	$150 → $150	Reiterates	Market Outperform → Market Outperform	Get Alert
06/20/2025	Buy Now	33.14%	JMP Securities	$150 → $150	Reiterates	Market Outperform → Market Outperform	Get Alert
06/10/2025	Buy Now	18.05%	Macquarie	$133 → $133	Maintains	Outperform	Get Alert
05/08/2025	Buy Now	18.05%	Macquarie	$129 → $133	Maintains	Outperform	Get Alert
04/22/2025	Buy Now	33.14%	JMP Securities	$150 → $150	Reiterates	Market Outperform → Market Outperform	Get Alert
04/10/2025	Buy Now	33.14%	JMP Securities	$150 → $150	Maintains	Market Outperform	Get Alert
03/12/2025	Buy Now	26.04%	Stephens & Co.	$142 → $142	Reiterates	Overweight → Overweight	Get Alert
02/27/2025	Buy Now	14.5%	Macquarie	$129 → $129	Maintains	Outperform	Get Alert
02/26/2025	Buy Now	26.04%	Stephens & Co.	$153 → $142	Maintains	Overweight	Get Alert
01/24/2025	Buy Now	33.14%	Oppenheimer	$145 → $150	Maintains	Outperform	Get Alert
12/16/2024	Buy Now	33.14%	JMP Securities	→ $150	Initiates	→ Market Outperform	Get Alert
11/14/2024	Buy Now	20.71%	RBC Capital	$136 → $136	Reiterates	Outperform → Outperform	Get Alert
11/06/2024	Buy Now	28.7%	Stephens & Co.	$143 → $145	Maintains	Overweight	Get Alert
11/06/2024	Buy Now	20.71%	RBC Capital	$141 → $136	Maintains	Outperform	Get Alert
11/04/2024	Buy Now	23.38%	Macquarie	$139 → $139	Maintains	Outperform	Get Alert
10/11/2024	Buy Now	23.38%	Macquarie	$139 → $139	Maintains	Outperform	Get Alert
10/11/2024	Buy Now	33.14%	Keybanc	→ $150	Initiates	→ Overweight	Get Alert
09/23/2024	Buy Now	28.7%	Oppenheimer	$140 → $145	Maintains	Outperform	Get Alert
09/03/2024	Buy Now	25.15%	RBC Capital	$141 → $141	Reiterates	Outperform → Outperform	Get Alert
08/08/2024	Buy Now	25.15%	RBC Capital	$129 → $141	Maintains	Outperform	Get Alert
08/08/2024	Buy Now	21.6%	TD Cowen	$128 → $137	Maintains	Buy	Get Alert
08/07/2024	Buy Now	26.93%	Stephens & Co.	$138 → $143	Maintains	Overweight	Get Alert
08/07/2024	Buy Now	24.26%	Oppenheimer	$130 → $140	Maintains	Outperform	Get Alert
08/06/2024	Buy Now	22.49%	Stephens & Co.	$138 → $138	Reiterates	Overweight → Overweight	Get Alert
06/28/2024	Buy Now	20.71%	Macquarie	→ $136	Initiates	→ Outperform	Get Alert
06/18/2024	Buy Now	13.61%	TD Cowen	$119 → $128	Maintains	Buy	Get Alert
06/07/2024	Buy Now	15.39%	Oppenheimer	$118 → $130	Maintains	Outperform	Get Alert
05/31/2024	Buy Now	13.61%	Stephens & Co.	$120 → $128	Maintains	Overweight	Get Alert
05/09/2024	Buy Now	5.63%	TD Cowen	$105 → $119	Maintains	Buy	Get Alert
05/07/2024	Buy Now	2.07%	Stephens & Co.	$115 → $115	Reiterates	Overweight → Overweight	Get Alert
05/07/2024	Buy Now	4.74%	B of A Securities	$115 → $118	Maintains	Buy	Get Alert
04/23/2024	Buy Now	-26.33%	Barclays	$88 → $83	Downgrade	Equal-Weight → Underweight	Get Alert
03/26/2024	Buy Now	4.74%	Oppenheimer	$118 → $118	Maintains	Outperform	Get Alert
03/06/2024	Buy Now	-21.89%	Barclays	→ $88	Initiates	→ Equal-Weight	Get Alert
02/29/2024	Buy Now	-9.46%	RBC Capital	$102 → $102	Reiterates	Outperform → Outperform	Get Alert
02/05/2024	Buy Now	—	William Blair	—	Assumes	→ Outperform	Get Alert
01/17/2024	Buy Now	4.74%	Oppenheimer	→ $118	Reiterates	Outperform → Outperform	Get Alert
12/12/2023	Buy Now	-6.8%	TD Cowen	→ $105	Initiates	→ Outperform	Get Alert
11/01/2023	Buy Now	-9.46%	RBC Capital	$109 → $102	Maintains	Outperform	Get Alert
11/01/2023	Buy Now	-6.8%	Stephens & Co.	$110 → $105	Maintains	Overweight	Get Alert
08/02/2023	Buy Now	4.74%	Oppenheimer	→ $118	Reiterates	Outperform → Outperform	Get Alert
08/02/2023	Buy Now	-6.8%	Raymond James	$100 → $105	Maintains	Outperform	Get Alert
08/02/2023	Buy Now	-2.36%	Stephens & Co.	$100 → $110	Maintains	Overweight	Get Alert
08/01/2023	Buy Now	-11.24%	Stephens & Co.	$100 → $100	Reiterates	Overweight → Overweight	Get Alert
06/29/2023	Buy Now	4.74%	Oppenheimer	$118 → $118	Reiterates	Outperform → Outperform	Get Alert
05/26/2023	Buy Now	4.74%	Oppenheimer	→ $118	Reiterates	Outperform → Outperform	Get Alert
05/05/2023	Buy Now	-11.24%	Raymond James	$125 → $100	Maintains	Outperform	Get Alert
05/03/2023	Buy Now	-3.25%	RBC Capital	$123 → $109	Maintains	Outperform	Get Alert
05/03/2023	Buy Now	4.74%	Oppenheimer	$130 → $118	Maintains	Outperform	Get Alert
05/02/2023	Buy Now	9.18%	Stephens & Co.	$123 → $123	Reiterates	Overweight → Overweight	Get Alert
04/05/2023	Buy Now	9.18%	Stephens & Co.	$123 → $123	Reiterates	Overweight → Overweight	Get Alert
03/06/2023	Buy Now	9.18%	RBC Capital	$121 → $123	Maintains	Outperform	Get Alert

FAQ

What is the target price for Addus HomeCare (ADUS) stock?

The latest price target for Addus HomeCare (NASDAQ:ADUS) was reported by BMO Capital on November 13, 2025. The analyst firm set a price target for $120.00 expecting ADUS to rise to within 12 months (a possible 6.51% upside). 19 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Addus HomeCare (ADUS)?

The latest analyst rating for Addus HomeCare (NASDAQ:ADUS) was provided by BMO Capital, and Addus HomeCare initiated their market perform rating.

When was the last upgrade for Addus HomeCare (ADUS)?

There is no last upgrade for Addus HomeCare

When was the last downgrade for Addus HomeCare (ADUS)?

The last downgrade for Addus HomeCare Corp happened on April 23, 2024 when Barclays changed their price target from $88 to $83 for Addus HomeCare Corp.

When is the next analyst rating going to be posted or updated for Addus HomeCare (ADUS)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Addus HomeCare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Addus HomeCare was filed on November 13, 2025 so you should expect the next rating to be made available sometime around November 13, 2026.

Is the Analyst Rating Addus HomeCare (ADUS) correct?

While ratings are subjective and will change, the latest Addus HomeCare (ADUS) rating was a initiated with a price target of $0.00 to $120.00. The current price Addus HomeCare (ADUS) is trading at is $112.66, which is within the analyst’s predicted range.